A certain biotech company's "Magic CC Needle" was launched globally, marking a new development in China's intelligent manufacturing of regenerative medical aesthetics

On May 8, 2025, the global launch event of the high-end regenerative medical aesthetic product "Magic CC Needle" (hydroxyapatite micro-spherical filling agent for injection) independently developed by a certain biotech company was grandly held at the Shanghai World Convention and Exhibition Hall. Mr. Ren Dawei, deputy director of the Shanghai Biomedical Science and Technology Industry Promotion Center, attended the event and delivered a speech. Leaders from government agencies such as the Science and Technology Commission and Economic Commission of Minhang District, Shanghai, as well as experts in plastic surgery from home and abroad, including the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences and Tongji Hospital Affiliated to Tongji University, witnessed this significant moment together. It marks that China's innovative medical aesthetics technology has entered the international high-end market and opened a new chapter in the global recycled materials field.